My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 253

    1.

    Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy.

    Perkins BA, Greene DA, Bril V.

    Diabetes Care. 2001 Apr;24(4):748-52.PMID: 11315842 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.

    Tkac I, Bril V.

    Diabetes Care. 1998 Oct;21(10):1749-52.PMID: 9773742 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy.

    Bril V, Perkins BA.

    Diabetes Care. 2002 Nov;25(11):2048-52.PMID: 12401755 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.

    Crook ED, Patel S.

    Ethn Dis. 2006 Autumn;16(4):865-71.PMID: 17061739 [PubMed - indexed for MEDLINE]Related articles

    5.

    Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy.

    Perkins BA, Ngo M, Bril V.

    Muscle Nerve. 2002 Feb;25(2):212-7.PMID: 11870689 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.

    Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR.

    J Diabetes Complications. 1997 Jan-Feb;11(1):27-34.PMID: 9025010 [PubMed - indexed for MEDLINE]Related articles

    7.

    GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.

    Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M.

    Am J Gastroenterol. 2002 Mar;97(3):604-11.PMID: 11922554 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Total antioxidant blood capacity in patients with type 2 diabetes mellitus and distal symmetrical polyneuropathy]

    Dordević G, Durić S, Apostolskit S, Dordević V, Zivković M.

    Vojnosanit Pregl. 2008 Sep;65(9):663-9. Serbian. PMID: 18814501 [PubMed - indexed for MEDLINE]Related articles

    9.

    The association between diabetic complications and exercise capacity in NIDDM patients.

    Estacio RO, Regensteiner JG, Wolfel EE, Jeffers B, Dickenson M, Schrier RW.

    Diabetes Care. 1998 Feb;21(2):291-5.PMID: 9539998 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.

    Bril V, Buchanan RA.

    Diabetes Care. 2006 Jan;29(1):68-72.PMID: 16373898 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes.

    McAlister FA, Man J, Bistritz L, Amad H, Tandon P.

    Diabetes Care. 2003 May;26(5):1518-24.PMID: 12716815 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of height and glycosylated hemoglobin in abnormal nerve conduction in pediatric patients with type I diabetes mellitus after 4-9 yr of disease.

    Duck SC, Wei FF, Parke J, Swick HM.

    Diabetes Care. 1991 May;14(5):386-92.PMID: 2060450 [PubMed - indexed for MEDLINE]Related articles

    13.

    Progression of distal symmetric polyneuropathy during diabetes mellitus: clinical, neurophysiological, haemorheological changes and self-rating scales of patients.

    Husstedt IW, Grotemeyer KH, Evers S, Staschewski F, Wertelewski R.

    Eur Neurol. 1997;37(2):90-4.PMID: 9058063 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.

    Christen WG, Manson JE, Bubes V, Glynn RJ.

    Am J Epidemiol. 1999 Dec 1;150(11):1142-51.PMID: 10588075 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.

    Perkins BA, Grewal J, Ng E, Ngo M, Bril V.

    Diabetes Care. 2006 Sep;29(9):2023-7.PMID: 16936147 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

    Bril V, Buchanan RA.

    Diabetes Care. 2004 Oct;27(10):2369-75.PMID: 15451902 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.

    Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A.

    J Diabetes Complications. 2001 May-Jun;15(3):150-7.PMID: 11358684 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.

    Jarmuzewska EA, Mangoni AA.

    J Intern Med. 2005 Jul;258(1):38-44.PMID: 15953131 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes.

    Chao CC, Hsieh SC, Yang WS, Lin YH, Lin WM, Tai TY, Hsieh ST.

    Diabetes Metab Res Rev. 2007 Nov;23(8):612-20.PMID: 17354257 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults.

    Berlin I, Bisserbe JC, Eiber R, Balssa N, Sachon C, Bosquet F, Grimaldi A.

    Diabetes Care. 1997 Feb;20(2):176-8.PMID: 9118768 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity